sanglah general chemotherapy at fluorouracil … · the risk factor of neutropenia on locally...
TRANSCRIPT
![Page 1: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,](https://reader030.vdocuments.us/reader030/viewer/2022041301/5e103123ccdf1944ed28b98a/html5/thumbnails/1.jpg)
THE RISK FACTOR OFNEUTROPENIA ON LOCALLY
ADVANCED BREAST CANCERPATIENTS TREATED WITH
FIRST CYCLECYCLOPHOSPHAMIDE,
DOXORUBICINE, 5-FLUOROURACIL
CHEMOTHERAPY ATSANGLAH GENERAL
FILE
TIME SUBMITTED 24-JUN-2016 09:28AM
SUBMISSION ID 686070371
WORD COUNT 2701
CHARACTER COUNT 15535
BMJ_2012_VOL_1_NO_3.DOCX (36.88K)
![Page 2: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,](https://reader030.vdocuments.us/reader030/viewer/2022041301/5e103123ccdf1944ed28b98a/html5/thumbnails/2.jpg)
HOSPITAL DENPASAR, BAby Dr. I Wayan Sudarsa
![Page 3: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,](https://reader030.vdocuments.us/reader030/viewer/2022041301/5e103123ccdf1944ed28b98a/html5/thumbnails/3.jpg)
![Page 4: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,](https://reader030.vdocuments.us/reader030/viewer/2022041301/5e103123ccdf1944ed28b98a/html5/thumbnails/4.jpg)
![Page 5: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,](https://reader030.vdocuments.us/reader030/viewer/2022041301/5e103123ccdf1944ed28b98a/html5/thumbnails/5.jpg)
![Page 6: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,](https://reader030.vdocuments.us/reader030/viewer/2022041301/5e103123ccdf1944ed28b98a/html5/thumbnails/6.jpg)
![Page 7: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,](https://reader030.vdocuments.us/reader030/viewer/2022041301/5e103123ccdf1944ed28b98a/html5/thumbnails/7.jpg)
FINAL GRADE
/0
THE RISK FACTOR OF NEUTROPENIA ON LOCALLYADVANCED BREAST CANCER PATIENTS TREATED WITHFIRST CYCLE CYCLOPHOSPHAMIDE, DOXORUBICINE, 5-FLUOROURACIL CHEMOTHERAPY AT SANGLAH GENERALHOSPITAL DENPASAR, BAGRADEMARK REPORT
GENERAL COMMENTS
Instructor
PAGE 1
PAGE 2
PAGE 3
PAGE 4
PAGE 5